Algoritmo de tratamiento con omalizumab en urticaria crónica espontánea.

Citation data:

Actas dermo-sifiliograficas, ISSN: 1578-2190, Vol: 109, Issue: 9, Page: 771-776

Publication Year:
2018
Captures 3
Readers 3
Social Media 2
Tweets 2
Citations 2
Citation Indexes 2
PMID:
30107875
DOI:
10.1016/j.ad.2018.07.005
Author(s):
J. Spertino; E. Rozas Muñoz; E. Serra Baldrich; L. Curto Barredo; A. Gimenez Arnau; I. Figueras Nart; M. Bonfill-Ortí; V. Expósito-Serrano; A. Guilabert; G. Melé Ninot; M. Villar Buil; J. Garcias Ladaria; X. García Navarro; M. Vilavella; I. Bielsa Marsol; G. Aparicio Ortiz; C. Baliu Piqué; A. Álvarez Abella; N. Lamas Domenech; J. M. Mascaró; S. Gómez; J. I. Torné Gutiérrez; A. Vicente Villa Show More Hide
Publisher(s):
Elsevier BV
Tags:
Medicine
Most Recent Tweet View All Tweets
article description
Pivotal trials with omalizumab for treatment of chronic spontaneous urticaria (CSU) are generally run over 12 to 24weeks. However, in clinical practice, many patients need longer treatment. In this article, we present an algorithm for treatment with omalizumab.